1.
|
10 p, 539.4 KB |
The Comparative Analysis of Two RT-qPCR Kits for Detecting SARS-CoV-2 Reveals a Higher Risk of False-Negative Diagnosis in Samples with High Quantification Cycles for Viral and Internal Genes
/
Luraschi, Roberto (Universidad de Santiago de Chile) ;
Barrera-Avalos, Carlos (Universidad de Santiago de Chile) ;
Vallejos Vidal, Eva Carolina (Universidad de Las Américas) ;
Alarcón, Javiera (Universidad de Santiago de Chile) ;
Mella-Torres, Andrea (Universidad de Santiago de Chile) ;
Hernández, Felipe (Universidad de Santiago de Chile) ;
Inostroza-Molina, Ailen (Universidad de Santiago de Chile) ;
Valdés, Daniel (Universidad de Santiago de Chile) ;
Imarai, Mónica (Universidad de Santiago de Chile) ;
Acuña-Castillo, Claudio (Universidad de Santiago de Chile) ;
Reyes-López, Felipe E. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Sandino, Ana María (Universidad de Santiago de Chile)
The early detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the real-time quantitative polymerase chain reaction (RT-qPCR) as a gold-standard molecular tool has allowed to test and trace the viral spread and the isolation of COVID-19-infected patients. [...]
2022 - 10.1155/2022/2594564
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale, Vol. 2022 (july 2022)
|
|
2.
|
16 p, 2.0 MB |
Prognostic implications of comorbidity patterns in critically ill COVID-19 patients : A multicenter, observational study
/
Benítez, Iván D. (Instituto de Salud Carlos III) ;
de Batlle, Jordi (Instituto de Salud Carlos III) ;
Torres, Gerard (Instituto de Salud Carlos III) ;
González, Jessica (Instituto de Salud Carlos III) ;
de Gonzalo Calvo, David (Instituto de Salud Carlos III) ;
Targa, Adriano D.S. (Instituto de Salud Carlos III) ;
Gort-Paniello, Clara (Instituto de Salud Carlos III) ;
Moncusí-Moix, Anna (Instituto de Salud Carlos III) ;
Ceccato, Adrian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Fernández-Barat, Laia (Hospital Clínic i Provincial de Barcelona) ;
Ferrer, Ricard (Hospital Universitari Vall d'Hebron) ;
Garcia-Gasulla, Dario (Barcelona Supercomputing Center) ;
Menéndez, Rosario (Hospital Universitari i Politècnic La Fe (València, Espanya)) ;
Motos, Anna (Hospital Clínic i Provincial de Barcelona) ;
Peñuelas, Oscar (Hospital Universitario de Getafe) ;
Riera del Brio, Jordi (Hospital Universitari Vall d'Hebron) ;
Bermejo-Martin, Jesús F. (Hospital Clínico Universitario de Valladolid) ;
Peñasco, Yhivian (Hospital Universitario Marqués de Valdecilla) ;
Ricart, Pilar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Martin Delgado, María Cruz (Hospital Universitario Torrejón) ;
Aguilera, Luciano (Hospital Universitario Basurto) ;
Rodríguez, Alejandro (Hospital Joan XXIII) ;
Boado Varela, Maria Victoria (Hospital de Cruces (Barakaldo, Biscaia)) ;
Suarez-Sipmann, Fernando (Hospital Universitario La Princesa) ;
Pozo-Laderas, Juan Carlos (Hospital Universitario Reina Sofia) ;
Solé-Violan, Jordi (Hospital Dr. Negrín Gran Canaria) ;
Nieto, Maite (Hospital Universitario de Segovia) ;
Novo, Mariana Andrea (Hospital Universitari Son Espases (Palma de Mallorca)) ;
Barberán, José (Hospital Universitario HM Montepríncipe) ;
Amaya-Villar, Rosario (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Garnacho-Montero, José (Hospital Universitario Virgen Macarena) ;
García-Garmendia, Jose Luis (Hospital San Juan de Dios del Aljarafe) ;
Gómez, José M. (Hospital General Universitario Gregorio Marañón) ;
Lorente, José Ángel (Hospital Universitario de Getafe) ;
Blandino Ortiz, Aaron (Hospital Universitario Ramón y Cajal (Madrid)) ;
Tamayo Lomas, Luis (Hospital Universitario Río Hortega de Valladolid) ;
López-Ramos, Esther (Hospital Universitario Príncipe de Asturias) ;
Úbeda, Alejandro (Hospital Punta de Europa) ;
Catalán-González, Mercedes (Hospital Universitario 12 de Octubre (Madrid)) ;
Sánchez-Miralles, Angel (Hospital de Sant Joan d'Alacant) ;
Martínez Varela, Ignacio (Hospital Universitario Lucus Augusti) ;
Jorge García, Ruth Noemí (Hospital Nuestra Señora de Gracia) ;
Franco, Nieves (Hospital Universitario de Móstoles (Madrid)) ;
Gumucio-Sanguino, Víctor D. (Hospital Universitari de Bellvitge) ;
Huerta Garcia, Arturo (Clínica Sagrada Família) ;
Bustamante-Munguira, Elena (Hospital Clínico Universitario (Valladolid)) ;
Valdivia, Luis Jorge (Hospital Universitario de León) ;
Caballero, Jesús (Hospital Universitari Arnau de Vilanova) ;
Gallego, Elena (Hospital Universitario San Pedro de Alcántara) ;
Martínez de la Gándara, Amalia (Hospital Universitario Infanta Leonor) ;
Castellanos-Ortega, Álvaro (Hospital Universitario y Politécnico La Fe) ;
Trenado Alvarez, Josep (Hospital Universitari Mútua de Terrassa) ;
Marin-Corral, Judith (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Albaiceta, Guillermo M. (Universidad de Oviedo) ;
de la Torre, Maria del Carmen (Hospital de Mataró. Consorci Sanitari del Maresme) ;
Loza-Vázquez, Ana (Hospital Universitario Virgen de Valme) ;
Vidal, Pablo (Complejo Hospitalario Universitario de Ourense) ;
Lopez Messa, Juan (Complejo Asistencial Universitario de Palencia) ;
Añón, Jose M. (Hospital Universitario La Paz) ;
Carbajales Pérez, Cristina (Hospital Álvaro Cunqueiro (Vigo)) ;
Sagredo, Victor (Hospital Universitario de Salamanca) ;
Bofill, Neus (Hospital Verge de la Cinta) ;
Carbonell, Nieves (Hospital Clínico y Universitario de Valencia) ;
Socias, Lorenzo (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
Barberà, Carme (Hospital Santa Maria) ;
Estella, Angel (Hospital Universitario de Jerez) ;
Valledor Mendez, Manuel (Hospital Universitario San Agustín) ;
Díaz Santos, Emilio (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
López Lago, Ana (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Torres, Antoni (Hospital Clínic i Provincial de Barcelona) ;
Barbé, Ferran (Instituto de Salud Carlos III) ;
Universitat Autònoma de Barcelona
The clinical heterogeneity of COVID-19 suggests the existence of different phenotypes with prognostic implications. We aimed to analyze comorbidity patterns in critically ill COVID-19 patients and assess their impact on in-hospital outcomes, response to treatment and sequelae. [...]
2022 - 10.1016/j.lanepe.2022.100422
The Lancet Regional Health - Europe, Vol. 18 (may 2022)
|
|
3.
|
11 p, 1.1 MB |
Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients : a retrospective multicenter study
/
Saura, Ouriel (CHU de Lille) ;
Rouzé, Anahita (Université de Lille) ;
Martin-Loeches, Ignacio (Hospital Clínic i Provincial de Barcelona) ;
Povoa, Pedro (Odense University Hospital (Dinamarca)) ;
Kreitmann, Louis (Hôpital Edouard Herriot) ;
Torres, Antoni (Hospital Clínic i Provincial de Barcelona) ;
Metzelard, Matthieu (CHU Amiens Picardie) ;
Du Cheyron, Damien (Caen University Hospital (França)) ;
Lambiotte, Fabien (Centre Hospitalier de Valenciennes) ;
Tamion, Fabienne (Rouen University Hospital (França)) ;
Labruyere, Marie (François Mitterrand University Hospital) ;
Boulle Geronimi, Claire (Centre Hospitalier de Douai) ;
Luyt, Charles-Edouard (Groupe Hospitalier Pitié-Salpêtrière) ;
Nyunga, Martine (Centre Hospitalier de Roubaix) ;
Pouly, Olivier (Hôpital Saint Philibert GHICL) ;
Thille, Arnaud W. (Université de Poitiers) ;
Megarbane, Bruno (Lariboisière Hospital) ;
Saade, Anastasia (Hôpital Saint-Louis) ;
Magira, Eleni (National and Kapodistrian University of Athens) ;
Llitjos, Jean-François (Hôpitaux de Paris) ;
Ioannidou, Iliana (National and Kapodistrian University of Athens) ;
Pierre, Alexandre (Centre Hospitalier de Lens) ;
Reignier, Jean (CHU de Nantes) ;
Garot, Denis (CHU de Tours) ;
Baudel, Jean-Luc (Hôpital Saint-Antoine) ;
Voiriot, Guillaume (Hôpital Tenon) ;
Plantefeve, Gaëtan (CH Victor Dupouy) ;
Morawiec, Elise (Assistance Publique-Hôpitaux de Paris) ;
Asfar, Pierre (CHU d'Angers) ;
Boyer, Alexandre (CHU de Bordeaux) ;
Mekontso-Dessap, Armand (Institut Mondor de Recherche Biomédicale) ;
Bardaka, Fotini (University of Thessaly) ;
Díaz Santos, Emilio (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Vinsonneau, Christophe (Hôpital de Béthune) ;
Floch, Pierre-Edouard (Hôpital Duchenne) ;
Weiss, Nicolas (Sorbonne Université) ;
Ceccato, Adrian (Hospital del Sagrat Cor (Barcelona, Catalunya)) ;
Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Nora, David (Hospital de São Francisco Xavier (Lisboa, Portugal)) ;
Duhamel, Alain (CHU de Lille) ;
Labreuche, Julien (CHU de Lille) ;
Nseir, Saad (Université de Lille) ;
Universitat Autònoma de Barcelona
Ventilator-associated pneumonia (VAP) is common in patients with severe SARS-CoV-2 pneumonia. The aim of this ancillary analysis of the coVAPid multicenter observational retrospective study is to assess the relationship between adjuvant corticosteroid use and the incidence of VAP. [...]
2022 - 10.1186/s13054-022-04170-2
Critical Care, Vol. 26 (september 2022)
|
|
4.
|
8 p, 641.4 KB |
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer : Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
/
Salvador Bofill, Javier (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Moreno Anton, Fernando (Hospital Clínico San Carlos (Madrid)) ;
Rodriguez Sanchez, Cesar Augusto (Hospital Universitario de Salamanca-IBSAL) ;
Galve Calvo, Elena (Hospital de Basurto (Bilbao, Biscaia)) ;
Hernando Melia, Cristina (Hospital Clínic Universitari (València)) ;
Ciruelos Gil, Eva Maria (Hospital Universitario 12 de Octubre (Madrid)) ;
Vidal Losada, Maria (Hospital Clínic i Provincial de Barcelona) ;
Jiménez-Rodriguez, Begoña (UGCI Oncología Médica Hospitales Regional y Virgen de la Victoria) ;
De la Cruz Merino, Luis (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Martínez Jañez, Noelia (Hospital Universitario Ramón y Cajal (Madrid)) ;
Villanueva Vazquez, Rafael (Institut Català d'Oncologia) ;
de Toro Salas, Ruben (Hospital Universitario de Jerez (Jerez de la Frontera)) ;
Anton Torres, Antonio (Hospital Universitario Miguel Servet (Saragossa)) ;
Alvarez Lopez, Isabel Manuela (Biodonostia Osasun Ikerketako Institutura (País Basc)) ;
Gavila Gregori, Joaquin (Fundació Institut Valencià d'Oncologia) ;
Quiroga Garcia, Vanesa (Institut Català d'Oncologia) ;
Vicente Rubio, Elena (Hospital Universitario Insular Gran Canaria) ;
De la Haba-Rodriguez, Juan (Universidad de Córdoba) ;
Gonzalez-Santiago, Santiago (Hospital Universitario San Pedro de Alcántara) ;
Diaz Fernandez, Nieves (Hospital Universitario San Juan de Alicante) ;
Barnadas i Molins, Agustí (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Cantos Sanchez de Ibargüen, Blanca (Hospital Puerta de Hierro Majadahonda) ;
Delgado Mingorance, Juan Ignacio (Hospital Universitario Infanta Cristina) ;
Bellet Ezquerra, Meritxell (Vall d'Hebron Institut d'Oncologia) ;
de Casa, Sonia (Novartis Farmacèutica, SA) ;
Gimeno, Asuncion (Novartis Farmacèutica, SA) ;
Martin, Miguel (Hospital General Universitario Gregorio Marañón) ;
Universitat Autònoma de Barcelona
Breast cancer is the most common malignancy and the second leading cause of cancer-related mortality in Spanish women. Ribociclib in combination with endocrine therapy (ET) has shown superiority in prolonging survival in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC) vs. [...]
2022 - 10.1016/j.breast.2022.09.006
Breast, Vol. 66 (september 2022) , p. 77-84
|
|
5.
|
11 p, 3.2 MB |
Study of Excipients in Delayed Skin Reactions to mRNA Vaccines : Positive Delayed Intradermal Reactions to Polyethylene Glycol Provide New Insights for COVID-19 Arm
/
Pesqué, David (Hospital del Mar (Barcelona, Catalunya)) ;
Pujol Vallverdú, Ramón M (Hospital del Mar (Barcelona, Catalunya)) ;
Marcantonio Santa Cruz, Orianna Yilsy (Hospital del Mar (Barcelona, Catalunya)) ;
Vidal-Navarro, Ainhoa (Hospital del Mar (Barcelona, Catalunya)) ;
Ramada Rodilla, José María (Hospital del Mar (Barcelona, Catalunya)) ;
Arderiu-Formentí, Alba (Hospital del Mar (Barcelona, Catalunya)) ;
Albalat-Torres, Agustí (Hospital del Mar (Barcelona, Catalunya)) ;
Serra, Consol (Hospital del Mar (Barcelona, Catalunya)) ;
Giménez Arnau, Ana M 1961- (Hospital del Mar (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona
Background: Skin local reactions to mRNA COVID-19 vaccines have been linked to the use of vaccine excipients. The aim of the study is to evaluate the role of skin testing excipients in delayed skin reactions due to mRNA COVID-19 vaccines. [...]
2022 - 10.3390/vaccines10122048
Vaccines, Vol. 10 (november 2022)
|
|
6.
|
8 p, 915.7 KB |
Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country : a case series analysis
/
Roure, Silvia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Vallès, Xavier (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Sopena, Nieves (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Benítez Díaz, Rosa María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Reynaga, Esteban (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bracke Manzanares, Carmen (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Loste, Cora (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Mateu, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Antuori Torres, Adrián (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Baena, Tania (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Portela, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Llussà, Judith (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Flamarich, Clara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Soldevila, Laura (Direcció Clínica Territorial de Malalties Infeccioses i Salut Internacional de Gerència Territorial Metropolitana Nord) ;
Tenesa, Montserrat (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pérez, Ricard (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Plasencia, Elsa (Subdirecció General de Vigilancia i Resposta a Emergències de Salut Pública) ;
Bechini Bernad, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pedro-Botet, Maria Lluïsa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Clotet Sala, Bonaventura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Vilaplana, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Disseminated tuberculosis is frequently associated with delayed diagnosis and a poorer prognosis. To describe case series of disseminated TB and diagnosis delay in a low TB burden country during the COVID-19 period. [...]
2023 - 10.3389/fpubh.2023.1175482
Frontiers in Public Health, Vol. 11 (may 2023)
|
|
7.
|
2 p, 73.0 KB |
Corrigendum : Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country: a case series analysis
/
Roure, Silvia (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Vallès, Xavier (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Sopena, Nieves (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Benítez Díaz, Rosa María (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Reynaga, Esteban (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Bracke Manzanares, Carmen (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Loste, Cora (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Mateu, Lourdes (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Antuori Torres, Adrián (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Baena, Tania (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Portela, Germán (Institut Català de la Salut) ;
Llussà, Judith (Institut Català de la Salut) ;
Flamarich, Clara (Institut Català de la Salut) ;
Soldevila, Laura (Direcció Clínica Territorial de Malalties Infeccioses i Salut Internacional de Gerència Territorial Metropolitana Nord) ;
Tenesa, Montserrat (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pérez, Ricard (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Plasencia, Elsa (Subdirecció General de Vigilancia i Resposta a Emergències de Salut Pública) ;
Bechini Bernad, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pedro-Botet, Maria Lluïsa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Clotet Sala, Bonaventura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Vilaplana, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Disseminated tuberculosis is frequently associated with delayed diagnosis and a poorer prognosis. To describe case series of disseminated TB and diagnosis delay in a low TB burden country during the COVID-19 period. [...]
2023 - 10.3389/fpubh.2023.1236874
Frontiers in Public Health, Vol. 11 (june 2023)
|
|
8.
|
|
9.
|
14 p, 1.9 MB |
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients : a randomised controlled trial
/
Chastre, Jean (Service de Médecine Intensive Réanimation. Institut de Cardiologie. Groupe Hospitalier Pitié-Salpêtrière. Assistance Publique-Hôpitaux de Paris. Sorbonne University) ;
François, Bruno (Réanimation Polyvalente and Inserm CIC 1435 & UMR 1092. CHU) ;
Bourgeois, Marc (AZ Sint-Jan Brugge-Oostende AV) ;
Komnos, Apostolos (General Hospital of Larissa) ;
Ferrer, Ricard (Hospital Universitari Vall d'Hebron) ;
Rahav, Galia (Chaim Sheba Medical Center. Sackler School of Medicine. Tel Aviv University) ;
De Schryver, Nicolas (Clinique Saint-Pierre) ;
Lepape, Alain (Hospices Civils de Lyon Hôpital Lyon Sud) ;
Koksal, Iftihar (Faculty of Medicine. Trabzon and Acibadem University Faculty of Medicine. Karadeniz Technical University) ;
Luyt, Charles-Edouard (Service de Médecine Intensive Réanimation. Institut de Cardiologie. Groupe Hospitalier Pitié-Salpêtrière. Assistance Publique-Hôpitaux de Paris. Sorbonne University) ;
Sánchez-García, Miguel (Hospital Clínico San Carlos. Unidad de Cuidados Intensivos) ;
Torres, Antoni (Hospital Clínic i Provincial de Barcelona. Servei de Pneumologia) ;
Eggimann, Philippe (Department of Locomotor Apparatus. Centre Hospitalier Universitaire Vaudois CHUV) ;
Koulenti, Despoina (2nd Critical Care Department. Attikon University Hospital. National and Kapodistrian. University of Athens) ;
Holland, Thomas L. (Duke Clinical Research Institute) ;
Ali, Omar (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ;
Shoemaker, Kathryn (Respiratory and Immunology. BioPharmaceuticals R&D. AstraZeneca) ;
Ren, Pin (Respiratory and Immunology. BioPharmaceuticals R&D. AstraZeneca) ;
Sauser, Julien (Infection Control Program. Faculty of Medicine. Geneva University Hospitals) ;
Ruzin, Alexey (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ;
Tabor, David E. (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ;
Akhgar, Ahmad (Clinical Pharmacology and Quantitative Pharmacology. Clinical Pharmacology and Safety Sciences. BioPharmaceuticals R&D. AstraZeneca) ;
Wu, Yuling (Clinical Pharmacology and Quantitative Pharmacology. Clinical Pharmacology and Safety Sciences. BioPharmaceuticals R&D. AstraZeneca) ;
Jiang, Yu (Clinical Pharmacology and Quantitative Pharmacology. Clinical Pharmacology and Safety Sciences. BioPharmaceuticals R&D. AstraZeneca) ;
DiGiandomenico, Antonio (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ;
Colbert, Susan (Oncology. US SM&M. AstraZeneca) ;
Vandamme, Drieke (Inserm CIC 1435. CHU) ;
Coenjaerts, Frank (University Medical Center Utrecht) ;
Malhotra-Kumar, Surbhi (University of Antwerp. Laboratory of Medical Microbiology) ;
Timbermont, Leen (University of Antwerp. Laboratory of Medical Microbiology) ;
Oliver, Antonio (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Barraud, Olivier (INSERM U1092. Centre Hospitalier Universitaire de Limoges. Université Limoges) ;
Bellamy, Terramika (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ;
Bonten, Marc (Julius Center for Health Science and Primary Care. University Medical Center Utrecht. Utrecht University) ;
Goossens, Herman (Laboratory of Medical Microbiology. Vaccine and Infectious Disease Institute. University of Antwerp) ;
Reisner, Colin (DevPro Biopharma) ;
Esser, Mark T. (Clinical Research and Development. Vaccines and Immune Therapies. BioPharmaceuticals R&D. AstraZeneca Biopharmaceuticals) ;
Jafri, Hasan S. (Late-Stage Development. Respiratory and Immunology. BioPharmaceuticals R&D. AstraZeneca) ;
Joannidis, Michael ;
Klimscha, Walter ;
De Waele, Elisabeth ;
Devriendt, Jacques ;
Huberlant, Vincent ;
Depuydt, Pieter ;
Van Boxstael, Sam ;
Peric, Mladen ;
Kopic, Jasminka ;
Hanauer, Michal ;
Hruby, Tomas ;
Sramek, Vladimir ;
Svoboda, Petr ;
Vymazal, Tomas ;
Novacek, Martin ;
Annane, Djillali ;
Mira, Jean-Paul ;
Souweine, Bertrand ;
Dequin, Pierre-François ;
Meziani, Ferhat ;
Stephan, François ;
Nseir, Saadalla ;
Gibot, Sebastien ;
Schwebel, Carole ;
Plantefeve, Gaetan ;
Diehl, Jean-Luc ;
Richard, Christian ;
Lamer, Christian ;
Klouche, Kada ;
Jaber, Samir ;
Zakynthinos, Epaminondas ;
Filntisis, Georgios ;
Zakynthinos, Spyros ;
Koutsoukou, Antonia ;
Saroglou, Georgios ;
Nikolaou, Charikleia ;
Vlachogianni, Glykeria ;
Pnevmatikos, Ioannis ;
Mandragos, Konstantinos ;
Kremer, Ildiko ;
Rozgonyi, Zsolt Dezso ;
Marjanek, Zsuzsa ;
Martin-Loeches, Ignacio ;
Singer, Pierre ;
Van Heerden, Vernon ;
Carmeli, Yehuda ;
Povoa, Pedro ;
AlvarezSeoane, Antonio ;
Moura, Pedro ;
Gonzalez, Filipe ;
Ramirez, Paula ;
Torres Marti, Antonio ;
Ferrer Roca, Ricard ;
Oteiza, Lorena ;
Escudero, Dolores ;
Piacentini, Enrique ;
Vera, Paula (Institut d'Investigació Biomèdica Sant Pau) ;
Tamayo, Luis ;
Gonzalez Gallego, Miguel Angel ;
Suberviola Canas, Borja ;
Figueira, Iglesias ;
Leon, Rafael ;
Korten, Volkan ;
Akova, Murat ;
Wyncoll, Duncan ;
Whitehouse, Tony ;
Hopkins, Phil ;
Sim, Malcolm ;
Golan, Yoav ;
Zervos, Marcus ;
Vazquez, Jose ;
Cherabuddi, Kartikeya ;
Smulian, George ;
Rouphael, Nadine ;
Welker, James ;
Sims, Mathew ;
Van Duin, David ;
McCarthy, Todd ;
Polk, Christopher
Background: Ventilator-associated pneumonia caused by Pseudomonas aeruginosa (PA) in hospitalised patients is associated with high mortality. The effectiveness of the bivalent, bispecific mAb MEDI3902 (gremubamab) in preventing PA nosocomial pneumonia was assessed in PA-colonised mechanically ventilated subjects. [...]
2022 - 10.1186/s13054-022-04204-9
Critical Care, Vol. 26 Núm. 1 (december 2022) , p. 355
|
|
10.
|
|